+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet

Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet

Acta Poloniae Pharmaceutica 71(5): 803-811

The study evaluated two novel coprocessed excipients (with two methods) as disintegrants in an orally disintegrating paracetamol tablet formulation. The tablets produced were assessed for mechanical properties with the use of friability and tensile strength while the release properties were assessed with wetting time, water absorption ratio, disintegration time and dissolution profile. The results obtained showed that the methods of coprocessing and disintegrant incorporation influenced the activities of the disintegrants. The novel disintegrant enhanced the mechanical properties of the tablets containing them as shown by lower friability and higher tensile strength of the tablets. The result further showed that the rate and amount of water absorbed, type of disintegrant and the method of disintegrant incorporation influenced the total amount of paracetamol released. The study concluded that the novel disintegrants will be effective in the formulation of orally disintegrating paracetamol tablets.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 053069540

Download citation: RISBibTeXText

PMID: 25362809

Related references

Flow, packing and compaction properties of novel coprocessed multifunctional directly compressible excipients prepared from tapioca starch and mannitol. Pharmaceutical Development and Technology 19(8): 901-910, 2014

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics. Drug Development and Industrial Pharmacy 40(7): 910-918, 2014

Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet. Archives of Pharmacal Research 2015:, 2015

Formulation study for orally disintegrating tablet using partly pregelatinized starch binder. Chemical and Pharmaceutical Bulletin 59(8): 959-964, 2011

Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compactibility and tablet stability. Powder Technology 241: 60-66, 2013

Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation. Aaps Pharmsci 6(2): E16, 2004

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy Treatment. Clinical Oncology ) 11(5): 340-347, 1999

Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet. Pakistan Journal of Pharmaceutical Sciences 27(5 Spec No): 1467-1475, 2014

Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation. Diabetes Management 2(5s): 3-11, 2012

Bioequivalence evaluation of orally disintegrating tablet of pentoxyverine citrate. Nan Fang Yi Ke Da Xue Xue Bao 30(7): 1621-1623, 2010

Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet. International Journal of Preventive Medicine 7: 120, 2016

Formulation and evaluation of a novel matrix-type orally disintegrating Ibuprofen tablet. Iranian Journal of Pharmaceutical Research 10(3): 469-479, 2011

Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol. International Journal of Pharmaceutics 448(1): 132-141, 2013

Orally disintegrating tablet of novel salt of antiepileptic drug: formulation strategy and evaluation. European Journal of Pharmaceutics and Biopharmaceutics 85(3 Pt B): 1300-1309, 2013

Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug. Pharmaceutical Development and Technology 20(1): 60-64, 2015